Eclipse Treatment Planning System version 13.MR2 [13.06.31 with Smart Segmentation Knowledge Bas...
FDA Device Recall #Z-0990-2017 — Class II — December 2, 2016
Recall Summary
| Recall Number | Z-0990-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | December 2, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Varian Medical Systems, Inc. |
| Location | Palo Alto, CA |
| Product Type | Devices |
| Quantity | 42 devices are affected |
Product Description
Eclipse Treatment Planning System version 13.MR2 [13.06.31 with Smart Segmentation Knowledge Based Contouring version 2.3 [2.3.12] Radiology: The Eclipse Treatment Planning System (Eclipse TPS) is used to plan radiotherapy treatments for patients with malignant or benign diseases. Eclipse TPS is used to plan external beam irradiation with photon, electron and proton beams, as well as for internal irradiation (brachytherapy) treatments.
Reason for Recall
Modifications in version 13.6MR2 for Contouring, SmartAdapt, and SmartSegmentation workspaces resulted in contours not being saved consistently in Eclipse. Treatment Planning System. The issue only occurs if certain conditions are fulfilled.
Distribution Pattern
US Distribution to the states of : NJ, TN. OR and FL.
Lot / Code Information
Model # H48 Serial numbers: H48L574 H48L575 H48L576 H48L577 H48L578 H48L579 H48L580 H48L581 H48L582 H48L583 H48L584 H48L585 H48L586 H48L587 H482484 H487302 H48A587 H48D957 H480113 H480118 H481884 H481885 H481886 H481916 H481917 H484198 H484199 H488949 H48A680 H48A871 H48A872 H48A873 H48A874 H48A875 H48A876 H48A877 H48A878 H48A879 H48I531 H481195 H481236 H481237.
Other Recalls from Varian Medical Systems, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1899-2020 | Class II | Varian Multileaf Collimator [MLC]; Millenium Mu... | Aug 12, 2019 |
| Z-0771-2019 | Class II | Eclipse(TM) Treatment Planning System with Prot... | Dec 26, 2018 |
| Z-0077-2017 | Class II | Varian Head Frame - Model number HHF -ALL Head ... | Sep 13, 2016 |
| Z-2149-2016 | Class II | Optical Surface Monitoring System{OSMS, Varian ... | Jun 23, 2016 |
| Z-2150-2016 | Class II | Optical Surface Monitoring System{Align RT Plus... | Jun 23, 2016 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.